Financing - April 8, 2021
AlgoDx raises SEK 13 million
AlgoDx has announced that all existing investors have committed to a follow-up investment summing up to 13 MSEK (approximately 1.25 MEUR). The round was led by Nascent Invest with participation from angel investors Tomas Mora-Morrison, co-founder of Cambio Healthcare Systems, and Fredrik Sjödin. Accelerate projects The company intends to use the funds to continue to […]
Financing - March 22, 2021
Linköping University initiates AI project in digital pathology
The Center for Medical Image Science and Visualization (CMIV) will participate in an European collaboration for artificial intelligence in digital pathology. The project has received financing from the Innovative Medicines Initiative, a public-private partnership under the EU research and innovation programme, Horizon 2020, reports Linköping University. CMIV has a leading role In order to enable […]
Financing - March 22, 2021
Ascelia Pharma carries out a directed new share issue
The Issue will provide the company with SEK 200 million before transaction costs. Ascelia Pharma intends to use the net proceeds from the Issue for (i) financing the Phase II study for the oral chemotherapy drug candidate Oncoral, (ii) accelerating activities towards the commercialization of the diagnostic drug Mangoral, currently in an ongoing Phase III […]
Financing - March 17, 2021
Glooko raises USD 30 million
Glooko has raised a USD 30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. The new proceeds will accelerate execution of Glooko’s commercial strategy, including increasing adoption of Glooko’s remote patient monitoring platform, widening […]
Biotech Business - February 23, 2021
BioInvent carries out a directed share issue of USD 116 million
The company plans to in particular use the funds to prepare a clinical trial of their anti-FcγRIIB antibody BI-1206 for the treatment of Non-Hodgkin’s Lymphoma. The Board of Directors of BioInvent International has resolved to issue 19,095,000 shares in a directed share issue to international and Swedish institutional investors, where 2,834,399 New Shares are issued […]
Financing - February 17, 2021
EnginZyme extends Series A to EUR 11 million
The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. “The company represents the future of synthetic biology and the […]
